Veszprém, Hungary

Anió Szakácsné-Schmidt


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anió Szakácsné-Schmidt: Innovator in Pharmaceutical Compounds

Introduction

Anió Szakácsné-Schmidt is a notable inventor based in Veszprém, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyridine-1-oxide derivatives. His research focuses on the transformation of these compounds into effective medicinal ingredients.

Latest Patents

Anió holds a patent for a compound titled "Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds." This invention relates to N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboxamidine and its optically active enantiomers, specifically (R)-(−)-N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboxamidine and (S)-(+)-N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboxamidine. Additionally, the patent includes the preparation of N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboxyimidoyl chloride, which serves as an active ingredient in medicaments.

Career Highlights

Anió is currently associated with Cytrx Corporation, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new compounds that have the potential to improve therapeutic outcomes.

Collaborations

Throughout his career, Anió has collaborated with esteemed colleagues such as László Ürögdi and Zita Jegesné-Csákai. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Anió Szakácsné-Schmidt is a prominent figure in the field of pharmaceutical innovation, with a focus on pyridine-1-oxide derivatives. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…